Programme
| Heures |
événement |
(+)
|
|
08:15 - 09:00
|
Welcome coffee |
|
|
09:00 - 10:00
|
Presentation of Curamus programs |
|
|
09:00 - 09:05
|
Structuring SiRIC Curamus - Marc Sanson |
|
|
09:05 - 09:15
|
Neuro-oncology program - Marc Sanson |
|
|
09:15 - 09:25
|
Rare Immunohematological cancers program - Véronique Leblond |
|
|
09:25 - 09:35
|
Microsatellite Instability and Cancer program - Alex Duval |
|
|
09:35 - 09:45
|
Medical Humanities Integrated Group - Karine Berthelot-Guiet |
|
|
09:45 - 10:00
|
Questions, discussion |
|
|
10:00 - 11:00
|
Basic research - Genetics of tumors |
|
|
10:00 - 10:10
|
Genomic and functional analysis of chordoid gliomas - Bertille Bance |
|
|
10:10 - 10:20
|
Functional consequences of a recurrent SPI1 mutation in Waldenström’s macroglobulinemia - Damien Roos-Weil |
|
|
10:20 - 10:30
|
Genomic MSI: Gene Splicing Abnormalities in Colorectal Cancer with Microsatellite Instability - Vincent Jonchère |
|
|
10:30 - 10:40
|
What is this object called ‘’Tumor microenvironment’’? The view from history and philosophy of science - Anouk Barberousse |
|
|
10:40 - 11:00
|
Questions, discussion |
|
|
11:00 - 11:30
|
Pause café |
|
|
11:30 - 12:30
|
Prediction & Innovative Diagnosis |
|
|
11:30 - 11:40
|
Non invasive diagnosis of gliomas by spectro-MRI - Francesca Branzoli |
|
|
11:40 - 11:50
|
Development of a NGS-based method for IGHV mutational status assessment in chronic lymphocytic leukemia - Frederic Davi |
|
|
11:50 - 12:00
|
Identification of the MSI phenotype at the time of next-generation sequencing - Toky Ratovomanana |
|
|
12:00 - 12:10
|
Do cancer biomarkers have a philosophical nature? - Jean-Cassien Billier |
|
|
12:10 - 12:30
|
Questions, discussion |
|
|
12:30 - 13:40
|
Déjeuner |
|
|
13:40 - 14:40
|
Innovative Therapies, Follow-up and Quality of Life |
|
|
13:40 - 13:50
|
MMR deficiency in gliomas, consequences for treatment - Mehdi Touat |
|
|
13:50 - 14:00
|
Immune checkpoint inhibitors in people living with HIV - Baptiste Abbar |
|
|
14:00 - 14:10
|
MSI/dMMR digestive cancers treated by checkpoint inhibitors - Raphaël Colle |
|
|
14:10 - 14:20
|
Patient’s information and expertise. The case of histiocytosis - Renaud Debailly & Fleur Cohen |
|
|
14:20 - 14:40
|
Questions, discussion |
|
|
14:40 - 15:10
|
Pause café |
|
|
15:10 - 16:30
|
Invited speakers |
|
|
15:10 - 15:40
|
The drivers of oncogenesis of brain tumors: a model for precision medicine - Antonio Iavarone |
|
|
15:40 - 16:10
|
Philosophy of Cancer - Marta Bertolaso |
|
|
16:10 - 16:30
|
Questions, discussion |
|
|
16:30 - 16:35
|
Closing remarks - Alex Duval |
|
|
Chargement...